. (2025). Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines. (e26928). Iranian Journal of Basic Medical Sciences, 28(12), e26928 doi: 10.22038/ijbms.2025.26928

. "Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines" .e26928 , Iranian Journal of Basic Medical Sciences, 28, 12, 2025, e26928. doi: 10.22038/ijbms.2025.26928

. (2025). 'Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines', Iranian Journal of Basic Medical Sciences, 28(12), e26928. doi: 10.22038/ijbms.2025.26928

, "Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines," Iranian Journal of Basic Medical Sciences, 28 12 (2025): e26928, doi: 10.22038/ijbms.2025.26928

. Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines. Iranian Journal of Basic Medical Sciences. 2025;28(12):e26928. doi: 10.22038/ijbms.2025.26928